Omnicell (OMCL)
(Delayed Data from NSDQ)
$31.70 USD
-0.54 (-1.67%)
Updated May 23, 2024 04:00 PM ET
After-Market: $31.71 +0.01 (0.03%) 4:46 PM ET
3-Hold of 5 3
B Value D Growth B Momentum C VGM
Brokerage Reports
Omnicell, Inc. [OMCL]
Reports for Purchase
Showing records 301 - 320 ( 326 total )
Company: Omnicell, Inc.
Industry: Medical Info Systems
Modest Q2 Beat: Raising Target to $19 While Reiterating BUY
Provider: AURIGA USA
Analyst: MANNHEIMER G
Company: Omnicell, Inc.
Industry: Medical Info Systems
Healthcare IT & Services -Life at the Top: Revisiting Health IT Valuations
Provider: AURIGA USA
Analyst: MANNHEIMER G
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Management Meetings Support Investment Thesis; Reiterate BUY
Provider: AURIGA USA
Analyst: MANNHEIMER G
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Quarter, Guidance In-line: Reiterate BUY & Raise Target to $17
Provider: AURIGA USA
Analyst: MANNHEIMER G
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Strong Results, Guidance Reiterated: Maintain Buy and $16 Price Target.
Provider: AURIGA USA
Analyst: MANNHEIMER G
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Management Meetings, Checks Confirm Not Losing Its Step: Reiterate Buy
Provider: AURIGA USA
Analyst: MANNHEIMER G
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Is the Healthcare IT Love Fest Over?
Provider: AURIGA USA
Company: Omnicell, Inc.
Industry: Medical Info Systems
Upgrading to BUY on Valuation: Price Target Remains $15
Provider: AURIGA USA